Atlas Trials

Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT)

Clinical trial NCT04640181 · COMPLETED

Trial details

NCT number
NCT04640181
Sponsor
St. David's HealthCare
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Covid19
Start date
2020-12-01
Primary completion
2021-06-28
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.